ribozyme for HBV(Immusol)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Nameribozyme for HBV(Immusol)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideSmall molecules > Nucleosides and nucleotide derivtives > Ribozyme

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesItherx Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesItherx Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A